HighTower Advisors
BNGO icon

HighTower Advisors’s Bionano Genomics BNGO Stock Holding History

HighTower Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24
Closed -$9K – 3589
2023
Q2 		$9K Hold
24
– – ﹤0.01% 3311
2023
Q1 		$16K Sell
24
-1
-4% -$888 ﹤0.01% 3164
2022
Q4 		$22K Buy
+25
New +$31.5K ﹤0.01% 3121
2022
Q3 		– Sell
-25
Closed -$20K – 3175
2022
Q2 		$20K Buy
+25
New +$25.7K ﹤0.01% 2995

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HighTower Advisors's BNGO Position: Q3 2023 in Review

HighTower Advisors sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 24 shares — an estimated $9K sold.

HighTower Advisors first reported a position in BNGO in Q2 2022 and held it in 4 quarters. The position peaked at $22K in Q4 2022. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • HighTower Advisors reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • HighTower Advisors sold 24 Bionano Genomics shares in Q3 2023, an estimated $9K.
  • HighTower Advisors first reported a position in Bionano Genomics in Q2 2022 and held it in 4 quarters.
  • HighTower Advisors's Bionano Genomics position peaked at $22K in Q4 2022.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on HighTower Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.